Lindahl advises Senzime AB on a directed new share issue of SEK 100 million
Lindahl has advised Senzime AB (publ) in connection with a directed new share issue that will provide the company with SEK 100 million before transaction costs.
The subscription price was determined through an accelerated bookbuilding process, with Carnegie Investment Bank acting as financial adviser.
About Senzime
Senzime AB is a company listed on Nasdaq Stockholm that develops and markets CE and FDA approved monitoring systems for patients undergoing anaesthesia.
Lindahl's team consisted of Mattias Prage, Andreas Mellberg and Michaela Larsson.
Do you want to know more? Contact:
Mattias Prage
Partner | AdvokatMichaela Larsson
Associate | AdvokatAndreas Mellberg
Counsel | AdvokatCarousel items
-
Cases and transactions
2/24/2026
Lindahl advises Medivir in directed share issue of SEK 45 million
Lindahl has acted as legal adviser to Medivir AB (publ) in connection with the company's directed share issue of SEK 45 million to Carl Bennet AB. The issue was carried out at a premium of 19 per cent to the closing price and has been well receive...
-
Knowledge
2/20/2026
Ambiguities and contradictions in construction contracts
Lindahl's construction law webinar addressed the interpretation of unclear contractual provisions, ranking in the event of conflicting contract documents and adjustment of delay penalties. The article summarises practical advice and recent case la...
-
News articles
2/12/2026
Lindahl ranked in Chambers and Partners Global Guide 2026
Lindahl is proud to once again be ranked in Chambers and Partners Global Guide. This year's ranking confirms the firm's strong position within several business-critical practice areas.
-
Portraits
1/20/2026
How I use AI in my daily work as a lawyer
AI is no longer the future – it is everyday reality. Johanna Karlsson, lawyer and senior associate at Lindahl, talks about how AI tools such as Legora have become a natural part of her workflow.
-
Read more news and insights?